ABSTRACT In six normal subjects treatment with 4 mg nedocromil sodium failed to alter the cough and bronchoconstriction induced by inhaled capsaicin. Because nedocromil has previously been shown to inhibit reflex bronchoconstriction provoked by inhaled sulphur dioxide and inhaled bradykinin, the results suggest that inhaled capsaicin acts on different nerve fibres.
Nedocromil sodium is a potent inhibitor of mucosal and connective tissue mast cells in primates and it inhibits antigen induced bronchoconstriction in man.' It is also a potent inhibitor of reflex bronchoconstriction induced by inhaled sulphur dioxide2 and bradykinin,3 both of which may act by stimulating airway C fibres. Capsaicin, the active ingredient ofred pepper, in animals has been shown to stimulate C fibres accessible to both pulmonary and bronchial artery circulation. Inhaled capsaicin in man causes reproducible cough4 and bronchoconstriction.5 These effects are inhibited by lignocaine4 and muscarinic antagonists,5 suggesting that they are due to stimulation of a reflex mechanism. We have therefore examined whether inhaled nedocromil sodium (4 mg) alters the cough and reflex bronchoconstriction induced by inhaling capsaicin.
Methods
Six healthy subjects (three female) aged 23-34 years took part in the study, which had the permission of the local medical school ethics committee. For 936 capsaicin causing two or more coughs (D2) was not altered by treatment with placebo or nedocromil sodium (4 mg). The geometric mean (95% confidence intervals) (nmol) was 3-2 (3 2-3 2) before and 1-8 (1-2-2-8) after placebo and 1-6 (0-8-3 2) before and 1-6 (1.2-2-1) after nedocromil. The dose causing five or more coughs (D5) was also unaffected by either treatment, being 17 7 (7 0-44 7) before and 28-1 (22 3-35 4) after placebo and 9 9 (46-21 4) before and 9 9 (4-6-21-4) after nedocromil.
The percentage increase in R,S after a single breath of capsaicin was also unaffected by either treatment, the mean (95% confidence interval) percentage increase being 20 (8-6-31 4) before and 17 7 (7.9-27-5) after placebo and 18-0 (12 3-24 6) before and 22 5 (4-9-40-1) after nedocromil. The probability of a type 2 error (II) causing a change of one dilution of capsaicin for either D2 or D5 to be missed after nedocromil was < 0 005 (calculated from the between group variance of the data from the placebo day). The probability of a type 2 error (f) causing a 29% difference in R,3 to be missed was < 0 5 (calculated from data on the placebo day).
Discussion
In this study a single dose of4 mg inhaled nedocromil sodium did not alter either cough or reflex bronchoconstriction caused by inhaling capsaicin. The results are therefore the same as those observed with sodium cromoglycate,45 which, like nedocromil sodium, inhibits the reflex bronchoconstriction caused by sulphur dioxide7 and bradykinin.8 Capsaicin cough and bronchoconstriction challenges can be repeated on the same day as there is no tachyphylaxis to this response.45 The probability therefore of a false negative result is low. The study implies that capsaicin stimulates sensory nerves different from those stimulated by inhaled sulphur dioxide and bradykinin in man. Although all three substances have been shown to stimulate C fibres9 in Hansson, Choudry, Fuller, Pride animals it is possible that capsaicin stimulates C fibres in the larynx and the other substances fibres elsewhere in the airways. Alternatively, the substances may stimulate fibres of different anatomical types in man.
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